LB928 Distinguishing morphologic characteristics of cutaneous immune-related adverse events among patients receiving immune checkpoint inhibitors combined with other anti-cancer therapies

Autor: Asdourian, M.S., Jacoby, T.V., Shah, N., Semenov, Y., LeBoeuf, N., Reynolds, K., Dewan, A.K., Chen, S.
Zdroj: In Journal of Investigative Dermatology August 2022 142(8) Supplement:B13-B13
Databáze: ScienceDirect